Company: KOYNU
Filing Date: 2025-05-15
Form Type: DRS
Source: 0001829126-25-003675
Chunk: 315

Company: CSLM Digital Asset Acquisition Corp III, Ltd
Filing Date: 2025-05-15
Form: DRS
Chunk 315
---
 extent permitted by law, including for any
liability incurred in their capacities as such, except through their own actual fraud,
willful default or willful neglect. We expect to purchase a policy of directors’ and officers’ liability insurance that insures our officers and directors against the cost of defense,
settlement or payment of a judgment in some circumstances and insures us against our
obligations to indemnify our officers and directors.

Our officers and directors have agreed to waive any right, title, interest or claim
of any kind in or to any monies in the trust account, and have agreed to waive any
right, title, interest or claim of any kind they may have in the future as a result
of, or arising out of, any services provided to us and will not seek recourse against
the trust account for any reason whatsoever. Accordingly, any indemnification provided
will only be able to be satisfied by us if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business combination.

Our indemnification obligations may discourage shareholders from bringing a lawsuit
against our officers or directors for breach of their fiduciary duty. These provisions
also may have the effect of reducing the likelihood of derivative litigation against
our officers and directors, even though such an action, if successful, might otherwise
benefit us and our shareholders. Furthermore, a shareholder’s investment may be adversely affected to the extent we pay the costs of settlement
and damage awards against our officers and directors pursuant to these indemnification
provisions.

We believe that these provisions, the insurance and the indemnity agreements are necessary
to attract and retain talented and experienced officers and directors.

<div align='center'>185</div>

<div align='center'>SECURITIES ELIGIBLE FOR FUTURE SALE</div>

Immediately after this offering we will have 27,441,667 (or 31,482,917 if the over-allotment option is exercised in full) ordinary shares outstanding. Of these shares,
the 20,000,000 (or 23,000,000 if the over-allotment option is exercised in full) Class A ordinary shares sold in this offering will be freely tradable without restriction
or further registration under the Securities Act, except for any shares purchased
by one of our affiliates within the meaning of Rule 144 under the Securities Act. All of the 6,666,667 founder shares (or 7,666,667 if the over-allotment